Skip to main content
. 2003 Jan 7;138(1):261–271. doi: 10.1038/sj.bjp.0705028

Figure 3.

Figure 3

Effects of the phospholipase D inhibitor butan-1-ol and its negative control butan-2-ol (0.3% each) on NA- and SPC-induced vasoconstriction. Data are means±s.e.mean of six experiments. P<0.0001 for overall treatment effects of butan 1-ol-vs butan-2-ol against NA but not SPC effects in a two-way ANOVA; *P<0.05 for individual agonist concentrations vs butan-2-ol in Bonferroni post-tests.